TP53 and breast cancer: To characterize the HBAP functional groups that interacted with DBD of the mutant p53, four HBAP derivatives were synthesized (Figure 4C) and added to breast cancer cells (MDA-MB-468) that contained a mutant p53 (p53R273H).